EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

Files
main.pdf (257.48 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2023
Authors
Li, Yong
Xu-Monette, Zijun Y.
Abramson, Jeremy
Sohani, Aliyah R.
Bhagat, Govind
Tzankov, Alexandar
Visco, Carlo
Zhang, Shanxiang
Dybkaer, Karen
Pan, Zenggang
Xu, Min
Tam, Wayne
Zu, Youli
Hsi, Eric D.
Hagemeister, Fredrick B.
Go, Heounjeong
van Krieken, J. Han
Winter, Jane N.
Ponzoni, Maurilio
Ferreri, Andrés J. M.
Møller, Michael B.
Piris, Miguel A.
Wang, Yingjun
Zhang, Mingzhi
Young, Ken H.
Language
American English
Embargo Lift Date
Department
Pathology and Laboratory Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
American Society of Hematology
Abstract
Description
Keywords
Clonal Hematopoiesis, DNA (Cytosine-5-)-Methyltransferases, DNA Methyltransferase 3A, Mutation
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Li Y, Xu-Monette ZY, Abramson J, et al. EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2023;7(7):1308-1311. doi:10.1182/bloodadvances.2022008550
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Blood Advances
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/37460
DOI
https://doi.org/10.1182/bloodadvances.2022008550
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Pathology and Laboratory Medicine Works